GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)

Clinical trial NCT06309732 · COMPLETED

Trial details

NCT number: NCT06309732
Sponsor: Queen Mary University of London
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Testicular Neoplasms

Start date: 2006-07-01
Primary completion: 2013-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.